Company / Current Liabilities
Bionano Genomics, Inc. Current Liabilities History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$22.9M
FY2025
5-year range
$21.8M / $100.0M
FY2021-FY2025
Trend
-38.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 8 years, ranging from $5M in FY2018 to $100M in FY2023.
Based on SEC 10-K filings.
$23M in FY2025 with a 5-year CAGR of +20.7%.
Improved from $100M to $23M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -13.9%
- 5-Year CAGR
- +20.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +20.7%, indicating consistent growth.
- In FY2025, current liabilities decreased 38.6% year-over-year.
- Peak current liabilities was recorded in FY2023.
- Lowest current liabilities in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.9M | -38.6% |
| FY2024 | $37.3M | -62.7% |
| FY2023 | $100.0M | +178.8% |
| FY2022 | $35.9M | +64.3% |
| FY2021 | $21.8M | +144.2% |
| FY2020 | $8.9M | -66.1% |
| FY2019 | $26.4M | +483.0% |
| FY2018 | $4.5M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026